SCOLR Pharma (DDD) Announces Positive Ibuprofen Study Results and Status of Commercialization Program
Tweet Send to a Friend
SCOLR Pharma, Inc. (AMEX: DDD) announced two additional positive pharmacokinetics trials evaluating its extended-release ibuprofen OTC product candidate.
This article: 235 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 235 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
